CENTRE DE MALADIES THROMBOTIQUES
ActiveSummary
CENTRE DE MALADIES THROMBOTIQUES has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €23,645 and a net result of -€2,631. Equity has been shrinking by about 6.4% per year since 2018. The computed 12-month bankruptcy probability is 1.1% (low).
Overview
Official details
Source: KBO- Status
- Active since 21-11-1988 Normal situation
- Activity
- No activity registered in the KBO
- Financial year end
- 31 December
- Peppol
- Reachable since 09-04-2026
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.1%
- Gross margin
- -€1,779
- Loss
- €2,631
- Equity
- €23,645
- ▼ 10.0%
- Total assets
- €31,384
- ▲ 7.3%
- 2025 accounts not filed, 94 days past the deadline
Score breakdownraises riskCapped at 59: a confirmed filing findingFigures for financial year 2024 (filed on 30-08-2025)lowers riskFounded in 1988Size: total assets €31,384Equity €23,645 (75.3% of total assets)Show the evidence
Checked score
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity, 15% on profitability and 24% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 6 accounts on average 25 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (1)
Recent changes
- · Gazette deed Incorporation
Key facts about CENTRE DE MALADIES THROMBOTIQUES
- What is the company number of CENTRE DE MALADIES THROMBOTIQUES?
- The company number of CENTRE DE MALADIES THROMBOTIQUES is 0435.823.374. The VAT number is the same number with BE in front: BE 0435.823.374.
- Where is CENTRE DE MALADIES THROMBOTIQUES based?
- The registered office is at Drève du Tumulus 88, 1495 Villers-la-Ville.Company details
- What is the legal form of CENTRE DE MALADIES THROMBOTIQUES?
- The legal form of CENTRE DE MALADIES THROMBOTIQUES is Private limited company (pre-2019) (BVBA).
- When was CENTRE DE MALADIES THROMBOTIQUES founded?
- CENTRE DE MALADIES THROMBOTIQUES was founded on 21-11-1988.
- Is CENTRE DE MALADIES THROMBOTIQUES still active?
- Yes, CENTRE DE MALADIES THROMBOTIQUES is an active enterprise in the KBO register.
- What is the turnover of CENTRE DE MALADIES THROMBOTIQUES?
- The annual accounts for financial year 2024 state no turnover. The micro format does not require it.Financials
- Is CENTRE DE MALADIES THROMBOTIQUES profitable?
- In financial year 2024, CENTRE DE MALADIES THROMBOTIQUES made a loss of €2,631.
- Where can I find the annual accounts of CENTRE DE MALADIES THROMBOTIQUES?
- CENTRE DE MALADIES THROMBOTIQUES filed 36 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.